Name | Title | Contact Details |
---|
TrapX Security is the leader in deception technology. Our solution rapidly detects, analyzes and defeats new zero-day, targeted attacks, and malicious insiders. DeceptionGrid provides automated, highly accurate insight into malicious activities unseen by other types of cyber defenses.
Weee!, headquartered in Fremont, California, is the leading ethnic e-grocer in the United States. Serving coast-to-coast across 15 metropolitan regions, Weee! was founded in 2015 as a social e-commerce company to enable affordable access to hard-to-find and fresh ingredients directly from the source. As a merchandise-driven retailer, Weee! partners with local suppliers and leverages proprietary demand forecasting technology to reshape the grocery supply chain entirely. Weee! has received $100M+ in funding from DST Global, Goodwater Capital, iFly.vc, XVC, VMG, Lightspeed Ventures, and Silicon Valley Bank.
MarqVision is a company that provides an AI-powered SaaS platform to help global brands detect and remove counterfeits from online marketplaces, social media, and NFT platforms.
We make it easy for you to earn cryptocurrency for your time and data while engaging with the web as you normally do.
Businesses are finding themselves faced with transformative change, from cloud technology to big data. No better example than the life sciences industry which is transforming from a data-driven clinical enterprise to an information-driven one. As the EDC specialists OmniComm understands the power that an information-driven clinical enterprise can bring to your clinical research organization. OmniComm is the only company that provides our clients with a choice of best-of-breed EDC platforms that are purpose-built for their unique clinical research environments – Early Phase, Late Phase, Phase I-IV, device trials, Investigator Initiated. We bring the most advanced open and interoperable EDC platforms to our clients; through our innovative cloud technology and advanced API web services we provide our clients with information to make insight driven clinical data-based critical decisions, bringing medical therapies to patients faster with lower risk. OmniComm provides comprehensive solutions for clinical research with an extensive global experience from over 4,800 clinical trials. 4 of the 5 top CROs and 7 of the 10 largest Phase I Clinics run OmniComm EDC technologies.